Through the observation of the informed consent process in the current clinical trials of glioma conducted in our hospital,and based on the overall development of glioma clinical trials in our department,this paper analyzes the issues encountered during the signing of informed consent,especially among patients with different types of gliomas,particularly those with impaired functional areas and limited cognitive function.Discussions are undertaken,and solutions for rectification are proposed.By standardizing the signing of informed consent and adopting personalized informed consent for glioma participants with different conditions,their wishes are fully respected.This standardized process ensures that the rights and interests of participants are adequately protected and promotes the standardized,safe,and orderly conduct of clinical trials.
关键词
脑胶质瘤/临床试验/知情同意/受试者权益
Key words
glioma/clinical trial/informed consent/rights and interests of participants
维普
万方数据